US FDA accepts Incyte's NDA for myelofibrosis drug
04 August 2011
Donna Young
Please Login to read the full article.
04 August 2011
Donna Young
donna.young@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Incyte wins first US OK for JAK inhibitor with myelofibrosis drug Jakafi
- S*BIO looks for JAK2 inhibitor partners as it preps for Phase III
- YM BioSciences rises on PhI/II results showing promise for JAK1/JAK2 inhibitor for myelofibrosis
- S*BIO sees space for its JAK inhibitor despite ruxolitinib approval
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
